ArticleBreast cancer research and treatment2024

Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer.

Takayuki Iwamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.